Madrigal pharmaceuticals to present at the oppenheimer healthcare conference

Conshohocken, pa., march 09, 2022 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq: mdgl), a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (nash), announced today its management team will participate in the 32nd annual oppenheimer healthcare conference on tuesday, march 15, 2022 at 8:00 am et.
MDGL Ratings Summary
MDGL Quant Ranking